China NMPA Product Recall - Sherpa NX Guiding Catheter

Medtronic Inc., in conjunction with its subsidiary Medtronic (Shanghai) Management Co., Ltd., initiated a voluntary Class II recall of its Sherpa NX Guiding Catheter, as reported by the National Medical Products Administration (NMPA) on June 21, 2019. The reason for this recall stems from a manufacturing defect concerning the distal outer layer material of the affected catheters. This material issue could potentially compromise the device's integrity or performance during medical procedures, posing a risk to patient safety. The NMPA, as the governing regulatory body, oversees such actions to ensure compliance and protect public health. This Class II recall indicates that the product's use may lead to temporary or medically reversible adverse health consequences, or that the likelihood of serious adverse health consequences is remote. Medtronic is required to provide detailed information on the specific models, specifications, and batch numbers of the impacted products in a "Medical Device Recall Event Report Form." Healthcare facilities and distributors must identify, quarantine, and follow the company's instructions for returning or disposing of these affected devices. This action highlights the ongoing commitment of both the manufacturer and the regulatory authority to uphold product quality standards and address potential safety concerns promptly.